DEMİRKAN, F. G. Et Al. 2022. The preferential use of anti-interleukin 1 therapies in various pediatric rheumatic disorders: outcomes of treat-to-target approach. 28th European Paediatric Rheumatology Congress of the Paediatric Rheumatology European Association (PReS) , (PRAG, Czech Republic).

DEMİRKAN, F. G., AKGÜN, Ö., GULİYEVA, V., & AKTAY AYAZ, N., (2022). The preferential use of anti-interleukin 1 therapies in various pediatric rheumatic disorders: outcomes of treat-to-target approach . 28th European Paediatric Rheumatology Congress of the Paediatric Rheumatology European Association (PReS), PRAG, Czech Republic

DEMİRKAN, Fatma Et Al. "The preferential use of anti-interleukin 1 therapies in various pediatric rheumatic disorders: outcomes of treat-to-target approach," 28th European Paediatric Rheumatology Congress of the Paediatric Rheumatology European Association (PReS), PRAG, Czech Republic, 2022

DEMİRKAN, Fatma G. Et Al. "The preferential use of anti-interleukin 1 therapies in various pediatric rheumatic disorders: outcomes of treat-to-target approach." 28th European Paediatric Rheumatology Congress of the Paediatric Rheumatology European Association (PReS) , PRAG, Czech Republic, 2022

DEMİRKAN, F. G. Et Al. (2022) . "The preferential use of anti-interleukin 1 therapies in various pediatric rheumatic disorders: outcomes of treat-to-target approach." 28th European Paediatric Rheumatology Congress of the Paediatric Rheumatology European Association (PReS) , PRAG, Czech Republic.

@conferencepaper{conferencepaper, author={Fatma Gül DEMİRKAN Et Al. }, title={The preferential use of anti-interleukin 1 therapies in various pediatric rheumatic disorders: outcomes of treat-to-target approach}, congress name={28th European Paediatric Rheumatology Congress of the Paediatric Rheumatology European Association (PReS)}, city={PRAG}, country={Czech Republic}, year={2022}}